Key result
US cancer and AF-related mortality increases ~102% over the study period.
Why the study?
AF and cancer share risk factors and may compound mortality risk, but national trends in AF and cancer-related mortality remain underexplored.
Observational
Yes
Mortality from concurrent cancer and atrial fibrillation in the US has significantly increased from 1999 to 2019, with notable disparities across sex, race, and geography.
Answers are grounded in this paper and cite their sources.
May warrant integrated cardio-oncology vigilance; leaves open drivers of rising mortality and need for prospective studies.
Background: Atrial fibrillation (AF) is the most common cardiac arrhythmia, whereas cancer remains the second leading cause of death in the United States. Both conditions share several risk factors and may compound mortality risk. However, national trends in AF and cancer-related mortality remain underexplored. Objective: To assess trends in mortality related to AF and cancer among US adults from 1999 to 2019, using demographic and geographic stratifications. Methods: Data were obtained from the CDC WONDER Multiple Cause of Death data set. We identified individuals aged 25 years and older with AF (I48) and cancer (C00-C97) as an underlying or contributing cause of death. Age-adjusted mortality rates (AAMRs) per 100,000 population, average annual percentage change, and annual percentage change were calculated. Results: The AAMR for cancer and AF-related deaths increased from 4.95 (95% confidence interval [CI]: 4.84, 5.05) in 1999 to 10.01 (95% CI: 9.88, 10.13) in 2019 (average annual percentage change: 3.49 [95% CI: 3.39, 3.60]). Males had higher AAMRs than females (10.24 vs 5.13). Non-Hispanic Whites had the highest AAMRs (7.89), followed by non-Hispanic Blacks (4.53) and Hispanics (3.11). The Western region had the highest AAMR, and nonmetropolitan areas exhibited greater mortality rates than metropolitan areas. Individuals with lung cancer exhibited the highest AAMRs (1.65), followed by gastrointestinal cancer (1.52) and hematologic cancer (1.00). The lowest AAMRs were observed in prostate cancer (0.90) and breast cancer (0.65). Conclusion: Mortality from cancer and AF has increased over time, with significant disparities across sex, race, and geography. Targeted interventions are required to mitigate these disparities.
No takes yet. Share an insight, caveat, or question.
Saad et al. (2025) conducted an observational in Atrial fibrillation and cancer. Cancer and atrial fibrillation-related mortality in the US increased from 4.95 per 100,000 in 1999 to 10.01 in 2019.
Synapse has enriched 10 related papers. Consider them for comparative context: